Comparison of serum NEDD-9, CA 15-3, and CEA levels and PET metabolic parameters in breast cancer patients with 18 F-FDG PET / CT

Arslan, Esra; Aral, Hale; Aksoy, Tamer; Afsar, Cigdem; Karabulut, SENEM; Trabulus, Fadime; Gursu, Riza; Cermik, Tevfik

doi:10.1590/1806-9282.66.5.673

Comparison of serum NEDD-9, CA 15-3, and CEA levels and PET metabolic parameters in breast cancer patients with 18 F-FDG PET / CT

Arslan E., Aral H., Aksoy T., Afsar C. U., Karabulut S., Trabulus F. D. C., ...Daha Fazla

REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, cilt.66, sa.5, ss.673-679, 2020 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 66 Sayı: 5
Basım Tarihi: 2020
Doi Numarası: 10.1590/1806-9282.66.5.673
Dergi Adı: REVISTA DA ASSOCIACAO MEDICA BRASILEIRA
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, Directory of Open Access Journals
Sayfa Sayıları: ss.673-679
İstanbul Üniversitesi Adresli: Evet

Özet

OBJECTIVE: Analyze the over expression of neural precursor cell expressed developmentally down-regulated protein 9 (NEDD-9) deregulated associated with a poor prognosis in various carcinomas. Our objective was to investigate the relationship between the levels of NEDD-9, CA 15-3, and CEA and PET (SUVmax, MTV40, TLG40) with the clinical parameters of patients with breast cancer (BC).